Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer	Metastatic Castration-resistant Prostate Cancer; mCRPC	Active, not recruiting	Phase 1 / Phase 2	2025-04-06		NCT05340374

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peter MacCallum Cancer Centre, Australia	48

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peter MacCallum Cancer Centre	Melbourne	Australia	149
St Vincent's Hospital	Sydney	Australia	1

Clinical trials